Patent details

LUC00216 Product Name: Moxétumomab pasudotox

Basic Information

Publication number:
LUC00216
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP181741653
Legal Status:
Withdrawn
Application number:
LUC00216
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1522
Marketing Authorization Type:
Marketing Authorization Date:
09/02/2021
Marketing Authorization Status:
Claimed
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
15/07/2021
First Marketing Authorization date:
09/02/2021
Grant date:
Activation date:
Publication date:
16/07/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
09/02/2036
SPC Extension Expiration:
09/02/2036
Rejection date:
Withdrawal date:
22/12/2021

Owner

From:
15/07/2021
 
 

Name:
MEDIMMUNE LIMITED
Address:
Milstein Building, Granta Park, Cambridge CB21 6GH, United Kingdom (GB)

Agent

Name:
ARONOVA S.A.
From:
15/07/2021
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/09
Publication date:
03/08/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
VRV
Bulletin edition number:
2022/01
Publication date:
03/01/2022
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

Other

Note:
(03/11/2021) Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant
Filing date Document type Number of pages
15/07/2021 Marketing authorization 4
15/07/2021 Summary of the product caracteristics 36
15/07/2021 MA publication 10
15/07/2021 Marketing authorization 3
15/07/2021 Application Form 4
03/11/2021 Incoming Correspondence (Post) 1
15/07/2021 General Document 2
05/11/2021 Outgoing Correspondence 1
16/07/2021 Publication 1
16/07/2021 Outgoing Correspondence 1
22/12/2021 Incoming Correspondence (Post) 2
24/12/2021 Outgoing Correspondence 1